Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion an
- This topic has 0 replies, 1 voice, and was last updated 9 years, 3 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma.
http://www.ncbi.nlm.nih.gov/pubmed/25608663
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.